Modality-Agnostic
Targeted Therapeutics

Creating new standards of care for patients
Cancer tumor cell

A Deep And
Diversified Pipeline

We take a unique approach to research and development–by identifying high-impact targets and then pursuing the best modality–resulting in a deep and diverse pipeline.
homepipeline
 
Image of Circles
parallax-bg

Leveraging the Best Scientific Collaborations

Embedding external collaboration into our research model helps advance new ideas that have a higher chance of benefiting patients. Our own discovery efforts and exceptional engagement with academic and industry partners enable us to identify and deliver the most promising therapies. With a focus on reaching patients efficiently and expeditiously, we seek strategic industry collaborations to advance programs at the right time.

Innovation Without Borders

With patient benefit as our priority, and anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.
Cullinan research model engaging academic and industry partners

Cullinan Therapeutics
In The News

Read the latest news and information from Cullinan Therapeutics.
 
 
 

Join Our
Growing Team

Collaboration is key to how we work at Cullinan Therapeutics. The closer we work together—across teams, programs, backgrounds, and experiences—the better we can challenge the status quo.